US FDA Must Assess Business Impact Of Final Interstate Compounding MOU, Court Rules
Summary judgment puts 20-year-old effort to define ‘inordinate’ out-of-state drug compounding back on slow track.
Summary judgment puts 20-year-old effort to define ‘inordinate’ out-of-state drug compounding back on slow track.